We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+31.13%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$3.89B
AUM Growth
+$2.3B
Cap. Flow
+$1.81B
Cap. Flow %
46.45%
Top 10 Hldgs %
13.13%
Holding
1,688
New
594
Increased
357
Reduced
244
Closed
486

Top Buys

Rank Stock Value
1
TRP icon
TC Energy
TRP
+$113M
2
AMZN icon
Amazon
AMZN
+$61.7M
3
BABA icon
Alibaba
BABA
+$39.9M
4
CTEV
Claritev Corp
CTEV
+$30.3M
5
WPF.U
Foley Trasimene Acquisition Corp.
WPF.U
+$28.3M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$37M
2
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
+$30M
3
JD icon
JD.com
JD
+$29.9M
4
BILI icon
Bilibili
BILI
+$29.5M
5
CCX.U
Churchill Capital Corp II
CCX.U
+$25.9M

Sector Composition

Rank Sector Weight
1 Technology 19.6%
2 Consumer Discretionary 13.23%
3 Financials 10.89%
4 Industrials 10.19%
5 Healthcare 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRE icon
726
Sempra
SRE
$55.3B
$637K 0.02%
10,866
-5,188
-32% -$319K
MRTX
727
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$637K 0.02%
5,579
-11,076
-67% -$1.07M
YMAB
728
DELISTED
Y-mAbs Therapeutics
YMAB
$636K 0.02%
14,727
-1,063
-7% -$40.2K
AGO icon
729
Assured Guaranty
AGO
$3.66B
$635K 0.02%
26,032
-14,049
-35% -$383K
INGR icon
730
Ingredion
INGR
$6.51B
$634K 0.02%
+7,640
New +$625K
QNCX icon
731
Quince Therapeutics
QNCX
$28.2M
$631K 0.02%
+68
New +$623K
TPTX
732
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$625K 0.02%
+9,678
New +$558K
SMTC icon
733
Semtech
SMTC
$11.3B
$624K 0.02%
+11,957
New +$560K
FMX icon
734
Fomento Económico Mexicano
FMX
$42.4B
$619K 0.02%
9,988
+2,547
+34% +$162K
NOV icon
735
NOV
NOV
$6.95B
$619K 0.02%
50,528
+39,698
+367% +$488K
OTIC
736
DELISTED
Otonomy, Inc.
OTIC
$616K 0.02%
169,971
+141,800
+503% +$369K
ITW icon
737
Illinois Tool Works
ITW
$85.5B
$614K 0.02%
3,512
-1,988
-36% -$325K
PB icon
738
Prosperity Bancshares
PB
$8.94B
$614K 0.02%
+10,328
New +$596K
CCXI
739
DELISTED
ChemoCentryx, Inc.
CCXI
$614K 0.02%
+10,661
New +$580K
IBKC
740
DELISTED
IBERIABANK Corp
IBKC
$613K 0.02%
13,457
+6,432
+92% +$266K
UAL icon
741
United Airlines
UAL
$43.1B
$606K 0.02%
17,512
-1,038
-6% -$31.1K
NBIX icon
742
Neurocrine Biosciences
NBIX
$16.4B
$605K 0.02%
4,959
+2,458
+98% +$272K
AXS icon
743
AXIS Capital
AXS
$7.61B
$602K 0.02%
14,836
-23,364
-61% -$900K
STLA icon
744
Stellantis
STLA
$21.2B
$602K 0.02%
+59,886
New +$518K
AVYA
745
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$599K 0.02%
+48,461
New +$558K
DRNA
746
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$595K 0.02%
+23,432
New +$505K
IPGP icon
747
IPG Photonics
IPGP
$3.89B
$592K 0.02%
+3,694
New +$526K
IBRX icon
748
ImmunityBio
IBRX
$7.59B
$588K 0.02%
+47,818
New +$270K
USFD icon
749
US Foods
USFD
$22.1B
$587K 0.02%
29,759
-148,541
-83% -$2.84M
COR
750
DELISTED
Coresite Realty Corporation
COR
$586K 0.02%
+4,838
New +$582K
28 29
30
31 32

Similar funds

FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Schonfeld Strategic Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Schonfeld Strategic Advisors held 1,688 positions worth $3.89B, up 145% from $1.59B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Schonfeld Strategic Advisors deployed $1.81B of net new capital in Q2 2020, opening 594 new positions and adding to 357 existing holdings. Its largest new stake was Claritev Corp: 75,000 shares worth $32.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was JD.com, an estimated $29.9M trimmed.

  • Schonfeld Strategic Advisors's largest Q2 2020 buy was Claritev Corp: 75,000 shares worth $32.4M.
  • Schonfeld Strategic Advisors added most to TC Energy in Q2 2020, an estimated $113M increase.
  • Schonfeld Strategic Advisors's biggest Q2 2020 reduction was JD.com, cutting an estimated $29.9M.
  • Schonfeld Strategic Advisors fully exited Allergan plc in Q2 2020, selling an estimated $37M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 13% of its $3.89B portfolio in Q2 2020.
  • Schonfeld Strategic Advisors opened 594 new positions and closed 486 in Q2 2020.
  • Schonfeld Strategic Advisors's portfolio value rose 145% quarter-over-quarter to $3.89B.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.